Search

everythinglearnresearchcommunity

for

Search:↓

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Most patients improved with oral contraceptives, but some needed additional treatment.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Birth control pills can help reduce mild to moderate acne in women.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.